Vireo Growth (VREOF) Operating Leases (2020 - 2026)
Vireo Growth's (VREOF) quarterly Operating Leases came in at $174.4 million in Q1 2026, up 961.0% year-on-year from $16.4 million in Q1 2025, and up 19.21% quarter-over-quarter from $146.3 million in Q4 2025.
Vireo Growth (VREOF) Operating Leases (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Operating Leases across 7 years of filings, most recently posting $174.4 million for Q1 2026.
- Operating Leases for Q1 2026 came in at $174.4 million, up 961.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $174.4 million (up 961.0% YoY), and the FY2025 annual result was $146.3 million, up 786.97% from the prior year.
- Operating Leases came in at $174.4 million for Q1 2026 at Vireo Growth, up from $146.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $174.4 million in Q1 2026 to a low of $9.7 million in Q2 2023.
- The 5-year median for Operating Leases is $19.6 million (2024), against an average of $50.5 million.
- Across the five-year window, Operating Leases plunged 88.01% in 2023 and soared 961.0% in 2026, its largest moves.
- Vireo Growth's Operating Leases stood at $79.8 million in 2022, then slumped by 86.78% to $10.5 million in 2023, then soared by 56.44% to $16.5 million in 2024, then soared by 786.97% to $146.3 million in 2025, then climbed by 19.21% to $174.4 million in 2026.
- The last three Operating Leases figures came in at $174.4 million (Q1 2026), $146.3 million (Q4 2025), and $41.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 174.40 Mn |
| Dec 31, 2025 | 146.30 Mn |
| Sep 30, 2025 | 41.77 Mn |
| Jun 30, 2025 | 43.19 Mn |
| Mar 31, 2025 | 16.44 Mn |
| Dec 31, 2024 | 16.49 Mn |
| Sep 30, 2024 | 19.05 Mn |
| Jun 30, 2024 | 19.47 Mn |
| Mar 31, 2024 | 19.64 Mn |
| Dec 31, 2023 | 10.54 Mn |
| Sep 30, 2023 | 9.70 Mn |
| Jun 30, 2023 | 9.67 Mn |
| Mar 31, 2023 | 10.37 Mn |
| Dec 31, 2022 | 79.76 Mn |
| Sep 30, 2022 | 80.88 Mn |
| Jun 30, 2022 | 80.45 Mn |
| Mar 31, 2022 | 79.92 Mn |
| Dec 31, 2021 | 80.23 Mn |
| Sep 30, 2021 | 78.61 Mn |
| Jun 30, 2021 | 21.79 Mn |